Lavanya Rajachandran

Title: Lavanya Rajachandran: Innovator in GABA-Modulatory Compounds

Introduction

Lavanya Rajachandran is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of methods for screening GABA-modulatory compounds. With a total of 2 patents, his work focuses on enhancing cognitive and emotional health through innovative approaches.

Latest Patents

Rajachandran's latest patents involve methods for screening GABA-modulatory compounds for specified pharmacological activities. These methods are designed to assay compounds for cognitive enhancing properties, anxiolytic properties, hypnotic properties, or antidepressant properties. The processes include determining the in vitro efficacy and EC of the compounds at defined series of cloned GABA subtype receptors composed of specific variants of α, β, and γ subunits. This work aims to develop an activity profile for each compound. Additionally, the binding affinities of the compounds at GABA receptors are also assessed. As an extra step, the in vivo effects of the compounds may be tested in animal models.

Career Highlights

Rajachandran is currently associated with Neurogen Corporation, where he applies his expertise in pharmacological research. His innovative methods have the potential to lead to significant advancements in the treatment of various cognitive and emotional disorders.

Collaborations

Some of his notable coworkers include John Tallman and Dorothy Gallager, who contribute to the collaborative efforts at Neurogen Corporation.

Conclusion

Lavanya Rajachandran's work in the field of GABA-modulatory compounds showcases his commitment to advancing pharmacological research. His innovative methods hold promise for improving cognitive and emotional health through targeted therapies.